Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
about
Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disordersFrom Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related DisordersConditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviorsA randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Novel approaches in treatment of pediatric anxiety.D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorderDoes d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.Psychotherapy and medication management strategies for obsessive-compulsive disorder.D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysisThe effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER.Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disordersA high-throughput clinical assay for testing drug facilitation of exposure therapy.Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.Treating refractory obsessive-compulsive disorder: what to do when conventional treatment fails?Treating OCD: what to do when first-line therapies fail.Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder.D-cycloserine enhances generalization of fear extinction in children.RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.Electronic structure and conformational flexibility of D-cycloserine.Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers.Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.
P2860
Q24187995-090F3951-B357-405D-994B-BBBBEEBCBDF1Q26851172-BC479E44-E2EF-44C9-BB2E-FB06D6C5C9AEQ27006437-6DF1781B-F82C-4361-BE48-879EAF7B7270Q27009995-D0E515A9-77FD-4742-83ED-2F15E97D2AA7Q30426498-C14D4D32-6EB9-451A-ACC0-8E34328FE0FAQ30433318-ACBEBC62-1219-4227-9B5B-1B1395921C23Q30585383-47EBDB7F-1207-4C76-B478-C13E726D72AEQ31171981-EAA86DBA-1CB4-4A9A-8C66-7ED6F42BD4B2Q33598320-FE3535C6-08B2-4C15-A0FC-AE7DD3E4D981Q33760626-960B81C6-3DE3-4F3F-8A33-FF7E2DC8F62BQ33835384-7288CDDD-02BC-4404-97D3-92CA0814A975Q33956585-77DF20DD-E7C5-4751-BB55-945D0597DE4DQ34017493-9D160B4A-796C-4288-ACE7-B39FD55A3370Q34350942-F0F60E6A-D3B1-43C7-9910-8E108D3591E3Q34500045-2290724B-3E00-4DC8-A510-4EF47A1BD841Q34729257-F2DFFCC9-4366-4642-AA2C-E52258B02FB1Q35212987-094B88E6-1584-4F6B-8606-221042D44674Q35541703-BD46DE31-8852-4CA4-95D7-10DCC821F3D7Q36456733-B6FB38C8-69B2-49F9-9B2D-99203B9A7151Q36647465-BF978848-8F75-4174-868D-43000759504BQ36873932-C851AE2A-0825-4182-B463-F2141CC29CC1Q36977590-7E8546BC-B5B0-4AED-9DAC-88CEE9E95801Q37099618-61AEA70D-17EC-4189-963C-5498DBACB337Q37257029-769B83A0-D450-4CCC-9B25-3134F55F116DQ38154625-D1E0620F-72DC-4D5C-BCF5-D6AA37C5ABF6Q38390663-BD9A377A-9466-4128-9A93-50DB5DD5EDD0Q38448788-E55A8E2B-25D3-4D27-A750-317BDFC38B78Q38536162-F1DDA444-A151-43B8-83DD-18BD195AF00AQ39189451-456EA00D-7C4C-4A14-9436-FB5EFEA3977FQ47731098-DB5D2E5B-C696-40E1-BD62-659A6DCF5CC4Q48669254-C8B56558-A4BA-4558-BC6C-78A2F4D3BF5BQ50277576-57DC6516-3370-4776-B58D-340AA94F76E7Q50635570-75576DAB-09C1-4406-936C-34A4C764329DQ50741478-ACF1E10C-EBD0-4D83-9243-44D15264B295Q51843103-FF3A2F04-CC3B-4B3F-BF0E-3052236939C7
P2860
Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@en
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@nl
type
label
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@en
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@nl
prefLabel
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@en
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@nl
P2093
P1476
Need for speed: evaluating slo ...... y enhanced with d-cycloserine.
@en
P2093
David F Tolin
Gregory S Chasson
Hannah E Reese
Kaitlyn S Welsh
Sabine Wilhelm
Sowmya R Rao
Theresa Rowley
Ulrike Buhlmann
P304
P356
10.1016/J.BRAT.2010.03.007
P577
2010-03-16T00:00:00Z